Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable ...
TransThera Sciences Nanjing, Inc. (the TransThera) announced that the new drug application for Tinengotinib tablets has been ...
A recently cleared phase 3 study (NCT06051409) will evaluate olverembatinib combined with chemotherapy as a first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback